Headache medication and the COVID-19 pandemic

The world is currently dominated by the Corona Virus Disease 2019 (COVID-19) pandemic. Besides the obvious concerns about limitation of virus spread and providing the best possible care to infected patients, a concomitant concern has now arisen in view of a putative link between the use of certain d...

Descripción completa

Detalles Bibliográficos
Autores principales: MaassenVanDenBrink, Antoinette, de Vries, Tessa, Danser, A. H. Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183387/
https://www.ncbi.nlm.nih.gov/pubmed/32334535
http://dx.doi.org/10.1186/s10194-020-01106-5
_version_ 1783526410775691264
author MaassenVanDenBrink, Antoinette
de Vries, Tessa
Danser, A. H. Jan
author_facet MaassenVanDenBrink, Antoinette
de Vries, Tessa
Danser, A. H. Jan
author_sort MaassenVanDenBrink, Antoinette
collection PubMed
description The world is currently dominated by the Corona Virus Disease 2019 (COVID-19) pandemic. Besides the obvious concerns about limitation of virus spread and providing the best possible care to infected patients, a concomitant concern has now arisen in view of a putative link between the use of certain drugs, such as Renin-Angiotensin System (RAS) inhibitors and ibuprofen, and an increased risk for COVID-19 infection. We here discuss this concern in relation to headache treatment and conclude that, based on current evidence, there is no reason to abandon treatment of headache patients with RAS inhibitors or ibuprofen.
format Online
Article
Text
id pubmed-7183387
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-71833872020-04-27 Headache medication and the COVID-19 pandemic MaassenVanDenBrink, Antoinette de Vries, Tessa Danser, A. H. Jan J Headache Pain Commentary The world is currently dominated by the Corona Virus Disease 2019 (COVID-19) pandemic. Besides the obvious concerns about limitation of virus spread and providing the best possible care to infected patients, a concomitant concern has now arisen in view of a putative link between the use of certain drugs, such as Renin-Angiotensin System (RAS) inhibitors and ibuprofen, and an increased risk for COVID-19 infection. We here discuss this concern in relation to headache treatment and conclude that, based on current evidence, there is no reason to abandon treatment of headache patients with RAS inhibitors or ibuprofen. Springer Milan 2020-04-25 /pmc/articles/PMC7183387/ /pubmed/32334535 http://dx.doi.org/10.1186/s10194-020-01106-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
MaassenVanDenBrink, Antoinette
de Vries, Tessa
Danser, A. H. Jan
Headache medication and the COVID-19 pandemic
title Headache medication and the COVID-19 pandemic
title_full Headache medication and the COVID-19 pandemic
title_fullStr Headache medication and the COVID-19 pandemic
title_full_unstemmed Headache medication and the COVID-19 pandemic
title_short Headache medication and the COVID-19 pandemic
title_sort headache medication and the covid-19 pandemic
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183387/
https://www.ncbi.nlm.nih.gov/pubmed/32334535
http://dx.doi.org/10.1186/s10194-020-01106-5
work_keys_str_mv AT maassenvandenbrinkantoinette headachemedicationandthecovid19pandemic
AT devriestessa headachemedicationandthecovid19pandemic
AT danserahjan headachemedicationandthecovid19pandemic

Ejemplares similares